Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of cellular therapies designed to improve the lives of people living with serious disease. The company's cellular therapies uses incredible biological similarities between humans and other mammals to develop therapies by using animal cells and tissues, enabling pharmaceutical companies to develop a breakthrough therapeutic option for a debilitating disease.
Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
---|
This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.
Request full access to PitchBookInvestor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
---|
This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.
Request full access to PitchBook